Vineet Mishra Ralph C Daniel Craig A Elmets Anna Levin Boni E Elewski
J Drugs Dermatol
2013 Jan;12(1):16-7.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/23377322/
Anti-Inflammatory Agents / adverse effects Antibodies, Monoclonal, Humanized / adverse effects Nail Diseases / pathology Psoriasis / chemically induced Psoriasis / complications Skin / pathology
Anti-Inflammatory Agents / adverse effects Antibodies, Monoclonal, Humanized / adverse effects Nail Diseases / pathology Psoriasis / chemically induced Psoriasis / complications Skin / pathology Case Reports Letter Adalimumab Anti-Inflammatory Agents / therapeutic use Antibodies, Monoclonal, Humanized / therapeutic use Crohn Disease / complications Crohn Disease / drug therapy Exanthema / etiology Exanthema / pathology Female Humans Middle Aged Nails / pathology Paronychia / complications Pruritus / complications Pruritus / etiology Psoriasis / pathology Tumor Necrosis Factor-alpha / antagonists & inhibitors Anti-Inflammatory Agents Antibodies, Monoclonal, Humanized Tumor Necrosis Factor-alpha Adalimumab
PMC3971542
23377322
Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy
2013